Xuanzhu Biopharmaceutical Management

Management criteria checks 1/4

Xuanzhu Biopharmaceutical's CEO is Jiakui Li, appointed in Jun 2024, has a tenure of 1.33 years. directly owns 0.58% of the company’s shares, worth HK$102.40M. The average tenure of the management team and the board of directors is 0.9 years and 3.9 years respectively.

Key information

Jiakui Li

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	1.3yrs
CEO ownership	0.6%
Management average tenure	less than a year
Board average tenure	3.9yrs

Recent management updates

Recent updates

CEO

Jiakui Li (61 yo)

1.3yrs

Tenure

Dr. Jiakui Li has served as Director of Xuanzhu Biopharmaceutical Co. Ltd. since December 2018 and its general manager since June 2024 and joined the company in September 1, 2013. He was re-designated as t...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Yanjun Xu	Executive Chairman of the Board	5.4yrs	no data	0.91% HK$ 159.8m
Jiakui Li	GM & Executive Director	1.3yrs	no data	0.58% HK$ 102.4m
Cheng-Kon Shih	Chief Science Officer & Vice Chairman	6.8yrs	no data	0.33% HK$ 57.6m
Chengming He	Deputy GM & Board Secretary	less than a year	no data	no data
Tung Ching Ng	Joint Company Secretary	no data	no data	no data

0.9yrs

Average Tenure

53yo

Average Age

Experienced Management: 2575's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Yanjun Xu	Executive Chairman of the Board	5.4yrs	no data	0.91% HK$ 159.8m
Jiakui Li	GM & Executive Director	6.8yrs	no data	0.58% HK$ 102.4m
Cheng-Kon Shih	Chief Science Officer & Vice Chairman	6.8yrs	no data	0.33% HK$ 57.6m
Chi Chiu Fan	Independent Non-Executive Director	less than a year	no data	no data
Lifeng Wei	Non-Executive Director	3.9yrs	no data	no data
Huiying Li	Non-Executive Director	5.2yrs	no data	no data
Shuo Liu	Independent Non-Executive Director	3.8yrs	no data	no data
Yukui Wang	Independent Non-Executive Director	3.8yrs	no data	no data
Benyu Lu	Chairman of the Supervisory Board	3.9yrs	no data	no data
Xin Yue	Employee Representative Supervisor	3.9yrs	no data	no data
Yanling Chen	Non-Executive Director	less than a year	no data	no data
Xiaoping Wang	Supervisor	1.3yrs	no data	no data

3.9yrs

Average Tenure

49.5yo

Average Age

Experienced Board: 2575's board of directors are considered experienced (3.9 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/18 06:19
End of Day Share Price	2025/10/17 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Xuanzhu Biopharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.